Fundies.
English

Y-mAbs Therapeutics, Inc.

EDGAR
YMAB Quarterly report (10-Q) · filed 2025-08-08

Annual consolidated revenue for 2024: about Unit_Standard_USD_PqMS_P0DQESlyMjqI11yyA 87.69M, using the latest reported figures. The previous period, 2023, was about Unit_Standard_USD_PqMS_P0DQESlyMjqI11yyA 84.82M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments
Watchlist

Latest quarter

Revenue

19.5 million Unit_Standard_USD_UCH12tblP0KI5Pf5IlkutQ

2025 Q2 · Unit_Standard_USD_UCH12tblP0KI5Pf5IlkutQ

Exact inputs and evidence
  • Revenue: 19525000 Unit_Standard_USD_UCH12tblP0KI5Pf5IlkutQ Source

Operating margin

-28.7%

2025 Q2 · %

Exact inputs and evidence
  • Operating Income: -5604000 Unit_Standard_USD_UCH12tblP0KI5Pf5IlkutQ Source
  • Revenue: 19525000 Unit_Standard_USD_UCH12tblP0KI5Pf5IlkutQ Source
Cash and cash equivalents
62.3 million Unit_Standard_USD_UCH12tblP0KI5Pf5IlkutQ Source
Exact value

62293000 Unit_Standard_USD_UCH12tblP0KI5Pf5IlkutQ

Long-term debt including current maturities
Not available
Shares outstanding
45.4 million Unit_Standard_shares_o1PCc55yu02yInrSHTOXaw Source
Exact value

45438420 Unit_Standard_shares_o1PCc55yu02yInrSHTOXaw

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2025-08-08.

Financial data available through: 2024-12-31.

Coverage by financial measure
  • Revenue: 2 of 11 periods available· newest 2024-12-31
  • Operating income: 2 of 11 periods available· newest 2024-12-31
  • Net income: 2 of 11 periods available· newest 2024-12-31
  • Operating cash flow: 2 of 11 periods available· newest 2024-12-31
  • Capital expenditure: Multiple units; comparison withheld· newest 2021-12-31
  • Total assets: Multiple units; comparison withheld· newest 2024-12-31
  • Total liabilities: Multiple units; comparison withheld· newest 2024-12-31
  • Current assets: Multiple units; comparison withheld· newest 2024-12-31
  • Current liabilities: Multiple units; comparison withheld· newest 2024-12-31
  • Cash and cash equivalents: Multiple units; comparison withheld· newest 2024-12-31
  • long term debt: No compatible figures in this window
  • Shares outstanding: Multiple units; comparison withheld· newest 2024-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    +3.4%

    Prior period

    Unit_Standard_USD_PqMS_P0DQESlyMjqI11yyA 84.82 million

    –

    Current period

    Unit_Standard_USD_PqMS_P0DQESlyMjqI11yyA 87.69 million

    –

    Exact inputs and evidence

    87685000 − 84819000 = 2866000 Unit_Standard_USD_PqMS_P0DQESlyMjqI11yyA

    84819000 Unit_Standard_USD_PqMS_P0DQESlyMjqI11yyA · 2023-01-01 – 2023-12-31

    Inspect prior input Prior source

    87685000 Unit_Standard_USD_PqMS_P0DQESlyMjqI11yyA · 2024-01-01 – 2024-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    −Unit_Standard_USD_PqMS_P0DQESlyMjqI11yyA 8.24 million

    Prior period

    −Unit_Standard_USD_PqMS_P0DQESlyMjqI11yyA 21.43 million

    –

    Current period

    −Unit_Standard_USD_PqMS_P0DQESlyMjqI11yyA 29.67 million

    –

    Exact inputs and evidence

    -29666000 − -21427000 = -8239000 Unit_Standard_USD_PqMS_P0DQESlyMjqI11yyA

    -21427000 Unit_Standard_USD_PqMS_P0DQESlyMjqI11yyA · 2023-01-01 – 2023-12-31

    Inspect prior input Prior source

    -29666000 Unit_Standard_USD_PqMS_P0DQESlyMjqI11yyA · 2024-01-01 – 2024-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +Unit_Standard_USD_PqMS_P0DQESlyMjqI11yyA 11.52 million

    Prior period

    −Unit_Standard_USD_PqMS_P0DQESlyMjqI11yyA 27.23 million

    –

    Current period

    −Unit_Standard_USD_PqMS_P0DQESlyMjqI11yyA 15.71 million

    –

    Exact inputs and evidence

    -15714000 − -27232000 = 11518000 Unit_Standard_USD_PqMS_P0DQESlyMjqI11yyA

    -27232000 Unit_Standard_USD_PqMS_P0DQESlyMjqI11yyA · 2023-01-01 – 2023-12-31

    Inspect prior input Prior source

    -15714000 Unit_Standard_USD_PqMS_P0DQESlyMjqI11yyA · 2024-01-01 – 2024-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2024 2024-01-01 – 2024-12-31

  • Revenue Unit_Standard_USD_PqMS_P0DQESlyMjqI11yyA 87.69 million 100% of revenue
  • Cost of revenue Unit_Standard_USD_PqMS_P0DQESlyMjqI11yyA 15 million 17% of revenue
  • Operating expenses Unit_Standard_USD_PqMS_P0DQESlyMjqI11yyA 103.64 million 118% of revenue
  • Operating income −Unit_Standard_USD_PqMS_P0DQESlyMjqI11yyA 31.2 million −36% of revenue
  • Tax, interest and other Derived −Unit_Standard_USD_PqMS_P0DQESlyMjqI11yyA 1.54 million −1.8% of revenue
  • Net income −Unit_Standard_USD_PqMS_P0DQESlyMjqI11yyA 29.67 million −34% of revenue

Cash

  • Operating cash flow −Unit_Standard_USD_PqMS_P0DQESlyMjqI11yyA 15.71 million −18% of revenue
  • Capital expenditure Unavailable An input is unavailable.
  • Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2023 Operating loss: operating costs were 130% of revenue.
  • 2024 Operating loss: operating costs were 136% of revenue.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2023 2023-01-01 – 2023-12-3184819000 110491000 Derived -25672000 -4245000 Derived -21427000 Unavailable
Source
2024 2024-01-01 – 2024-12-3187685000 118886000 Derived -31201000 -1535000 Derived -29666000 Unavailable
Source

Amounts are exact, in Unit_Standard_USD_PqMS_P0DQESlyMjqI11yyA.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Unit_Standard_USD_PqMS_P0DQESlyMjqI11yyA 87.7M 2024
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.94.7M71.0M47.3M23.7M0.020232024
Values and sources
Revenue values and source evidence
PeriodSeriesValue(Unit_Standard_USD_PqMS_P0DQESlyMjqI11yyA)Source evidence
2023Revenue84819000
2024Revenue87685000

Revenue growth

Change in revenue from the same financial period one year earlier.

3.4% 2024
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.3.65%2.74%1.82%0.91%0.00%20232024
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2023Year over yearNo prior comparable period
2024Year over year3.4%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -35.6% 2024
Net margin -33.8% 2024
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.3%-7%-18%-28%-38%20232024
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2023Operating margin-30.3%
2024Operating margin-35.6%
2023Net margin-25.3%
2024Net margin-33.8%
2023Free cash flow marginNot reported
2024Free cash flow marginNot reported

Operating cash flow

Cash generated by the company’s normal business operations.

Unit_Standard_USD_PqMS_P0DQESlyMjqI11yyA -15.7M 2024
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.2.2M-5.7M-13.6M-21.5M-29.4M20232024
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(Unit_Standard_USD_PqMS_P0DQESlyMjqI11yyA)Source evidence
2023Operating cash flow-27232000
2024Operating cash flow-15714000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(Unit_Standard_USD_PqMS_P0DQESlyMjqI11yyA)Source evidence
2023Free cash flowUnavailable
2024Free cash flowUnavailable

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2023-12-31Liabilities / assetsNot reportedNo source recorded
2024-12-31Liabilities / assetsNot reportedNo source recorded

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2023-12-31Current assets / current liabilitiesNot reportedNo source recorded
2024-12-31Current assets / current liabilitiesNot reportedNo source recorded

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2023 2023-01-01 – 2023-12-31
−Unit_Standard_USD_PqMS_P0DQESlyMjqI11yyA 21.43 million
Exact value

Exact value: -21427000 Unit_Standard_USD_PqMS_P0DQESlyMjqI11yyA

2023-01-01 – 2023-12-31: -21427000 Unit_Standard_USD_PqMS_P0DQESlyMjqI11yyA Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_PqMS_P0DQESlyMjqI11yyA 27.23 million
Exact value

Exact value: -27232000 Unit_Standard_USD_PqMS_P0DQESlyMjqI11yyA

2023-01-01 – 2023-12-31: -27232000 Unit_Standard_USD_PqMS_P0DQESlyMjqI11yyA Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2024 2024-01-01 – 2024-12-31
−Unit_Standard_USD_PqMS_P0DQESlyMjqI11yyA 29.67 million
Exact value

Exact value: -29666000 Unit_Standard_USD_PqMS_P0DQESlyMjqI11yyA

2024-01-01 – 2024-12-31: -29666000 Unit_Standard_USD_PqMS_P0DQESlyMjqI11yyA Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_PqMS_P0DQESlyMjqI11yyA 15.71 million
Exact value

Exact value: -15714000 Unit_Standard_USD_PqMS_P0DQESlyMjqI11yyA

2024-01-01 – 2024-12-31: -15714000 Unit_Standard_USD_PqMS_P0DQESlyMjqI11yyA Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

32 filings · 3,382 latest values · 3,382 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001722964, 1722964, YMAB, edgar:1722964

Also known as Y-mAbs Therapeutics, Inc., Y-mAbs Therapeutics, Inc.